The global coronary stents market is experiencing steady growth, driven by the increasing prevalence of cardiovascular diseases, advancements in stent technology, and a rising demand for minimally invasive procedures.
Market Size and Growth
-
In 2024, the market was valued at approximately USD 8.3 billion and is projected to grow at a compound annual growth rate (CAGR) of 2.6% from 2025 to 2030.
-
Another analysis estimated the market size at USD 7.72 billion in 2025, with expectations to reach USD 9.51 billion by 2030, growing at a CAGR of 4.25% during the forecast period.
Key Market Drivers
-
Rising Incidence of Cardiovascular Diseases: The increasing prevalence of conditions such as coronary artery disease is a primary factor propelling market growth.
-
Technological Advancements: Innovations in stent design and materials, including the development of bioresorbable stents, are enhancing treatment outcomes and expanding the market.
-
Preference for Minimally Invasive Procedures: The growing demand for less invasive surgical interventions is boosting the adoption of coronary stents.
Product Segmentation
-
Drug-Eluting Stents (DES): These stents dominate the market due to their effectiveness in reducing restenosis rates.
-
Bare Metal Stents (BMS): While less commonly used than DES, BMS remain a viable option in certain clinical scenarios.
-
Bioresorbable Vascular Scaffolds: This emerging segment is gaining attention for its potential to reduce long-term complications associated with permanent implants.
Regional Insights
-
North America: Holds a significant market share, attributed to advanced healthcare infrastructure and high awareness levels.
-
Europe and Asia-Pacific: These regions are anticipated to experience considerable growth due to increasing healthcare expenditures and improved access to medical care.
Key Market Players
-
Abbott Laboratories
-
Medtronic plc
-
Boston Scientific Corporation
-
Terumo Corporation
-
BIOTRONIK SE & Co. KG
Looking for sample report, click here @ https://www.thebrainyinsights.com/enquiry/sample-request/12948
These companies are focusing on research and development to introduce innovative stent technologies, strategic collaborations, and expanding their market presence to strengthen their positions in the coronary stents market.
In summary, the coronary stents market is poised for steady growth, driven by increasing disease prevalence and advancements in stent technology. However, addressing challenges related to side effects, contraindications, and treatment costs will be crucial for sustained market expansion.
The global coronary stent market has been segmented based on stent type, application, mode of delivery, end user, and regions.
The stent type segment is divided into covered stent, drug-eluting stent, bioresorbable stent, bare metal stent, and others. The drug-eluting stents segment dominated the market, with a market share of around 25.67% in 2023. The continued improvement and takeoff of the latest devices are essential elements in supporting DES’s dominance as the best apparatus for PCI systems. The market prospects resume creating and establishing technologically advanced DES like XIENCE Skypoint, Medtronic’s Resolute Onyx, Abbott Laboratories’, and Boston Scientific’s Synergy.